Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The glycine-gated NMDA receptor is a subtype of the N-methyl-D-aspartate (NMDA) receptor, an ionotropic glutamate receptor. Unlike canonical NMDA receptors, glycine-gated forms (GluN1/GluN3) are activated exclusively by glycine, mediating excitatory neurotransmission and calcium influx in the CNS. These receptors are implicated in neuronal development and responses to pathological conditions.
Ligand-gated ion channel activation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycine-Gated NMDA Receptor.